The state of Delaware currently has 1 active clinical trials seeking participants for Multiple Sclerosis research studies. These trials are conducted in various cities, including Newark, Wilmington, Lewes and Rehoboth Beach.
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)
Recruiting
To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)
Gender:
ALL
Ages:
Between 18 years and 55 years
Trial Updated:
06/03/2025
Locations: Christiana Care Health Services, Newark, Delaware
Conditions: Relapsing Multiple Sclerosis